The company presented promising Phase II data, but it didn’t reveal its plans for a pivotal trial of ABBV-RGX-314, which would compete in a growing – but increasingly crowded – market.

Two gene therapies, from Molecular Therapeutics and Intellia Therapeutics respectively, are among the four new products the European Medicines Agency accepted onto it priority medicines scheme this month.

Results from a substudy of EAST2 focused on nodules without a bronchus sign or an airway leading to the nodule shows Broncus' Archimedes system, with proprietary virtual bronchoscopic navigation and "fused fluoroscopy" technology, provides access to nodules located anywhere in the lungs without puncturing the chest wall.

Liquid biopsy developer Laboratory for Advanced Medicine (LAM) named Jinjie Hu as chief regulatory officer.